Status:
UNKNOWN
Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
Lead Sponsor:
University of California, San Diego
Conditions:
Covid19
AKI
Eligibility:
All Genders
18+ years
Brief Summary
The coronavirus (COVID-19) pandemic has created a significant strain on health care resources across the world for managing critically ill patients. Emerging reports from China, South Korea and Italy ...
Detailed Description
Acute and Chronic kidney diseases are important causes of mortality and morbidity worldwide. The associated socioeconomic burden of kidney disease and AKI, as in some cases recovery is incomplete and ...
Eligibility Criteria
Inclusion
- Patients with confirmed infection with COVID 19
- Patients with Acute Kidney injury (AKI) or Chronic kidney disease (CKD) or need for dialysis
- Patients receiving Chronic dialysis (hemo or peritoneal dialysis)
- Renal transplant recipients
Exclusion
- • Patients \< 18 yrs age
Key Trial Info
Start Date :
May 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04491227
Start Date
May 5 2020
End Date
March 31 2023
Last Update
July 29 2020
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama, Birmingham
Birmingham, Alabama, United States, 35294
2
University of California, San Diego
San Diego, California, United States, 92103
3
University of Colorado
Aurora, Colorado, United States, 80045
4
St. Peter's Hospital
Albany, New York, United States, 12208